Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial

Journal of Human Hypertension

Volumn 15, Issue 9, 2001, Pages 613-618

  Celis, H ^a   Thijs, L ^a   Staessen, J A ^a   Birkenhager W H ^b   Bulpitt, C J ^c   De Leeuw, P W ^d   Leonetti, G ^e   Nachev, C ^f   Tuomilehto, J ^g   Fagard, R H ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

(Gastrointestinal) bleeding; Calcium channel blocker; Nonsteroidal anti inflammatory drug; Syst Eur trial

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; ENALAPRIL; HYDROCHLOROTHIAZIDE; NITRENDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELDERLY CARE; EUROPE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH HAZARD; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; OUTCOMES RESEARCH; PATIENT CODING; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM CHANNEL BLOCKERS; DRUG INTERACTIONS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 0034799769     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001235     Document Type: Article

References (31)

1. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
2. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
3. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease
4. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events
5. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs
6. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis
7. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons
8. Prophylactic aspirin and risk of peptic ulcer bleeding
9. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
10. Non-steroidal anti-inflammatory drugs and peptic ulcers
11. Non-steroidal anti-inflammatory drug gastropathy: Causes and treatment
12. No association between calcium channel blocker use and confirmed bleeding peptic ulcer
13. Nimodipine neuroprotection in cardiac valve replacement - Report of an early terminated trial
14. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old
15. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly
16. Major upper gastrointestinal bleeding and the use of calcium channel blockers
17. Antihypertensive drugs and the risk of gastrointestinal bleeding
18. Peptic ulcer bleeding: Accessory risk factors and interactions with non-steroidal anti-inflammatory drugs
19. Risk of gastrointestinal haemorrhage with calcium antagonists
20. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
21. Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol, and organization
22. Subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly
23. Secondary stroke prevention with low-dose aspirin, sustained release dipyramidole alone and in combination
24. Drug-induced gastrointestinal bleeding
25. Peptic ulcer bleeding in the elderly: Relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs
26. Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation
27. Antithrombogenic effects of calcium channel blockers: Synergism with prostacyclin and tromboxane synthase inhibitors
28. Aspirin with an adrenergic or calcium-channel blocking agent as a new combination therapy for arterial thrombosis
29. Inhibitory effect of clentiazem (TA-3090) on platelet aggregation - Alone and in combination with aspirin or ticlopidine
30. Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertension
31. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists